The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application, identified as TM90455390, for the mark ASPARGO. The application, filed on January 8, 2021, seeks protection for a range of goods including pump spray dispensers for medical purposes, oral spray devices for administering medicaments (specifically sildenafil for erectile dysfunction), pharmaceutical compounds, and drug delivery devices prefilled with pharmaceutical products.

This filing signifies a potential new market entry or brand expansion for products related to medical devices and pharmaceuticals. While this is a trademark application and not a regulatory rule, companies operating in the pharmaceutical and medical device sectors should be aware of new brand registrations that may impact their market or product naming strategies. No immediate compliance actions are required for other entities based on this trademark filing.